Daiichi Sankyo & AstraZeneca

Verified Pharmaceutical Manufacturer & Oncology Drug Supplier

Back to Pharmaceuticals Directory

Daiichi Sankyo & AstraZeneca

Verified Partner

Registered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.

Company Profile & Registration

Legal Organization NameDaiichi Sankyo & AstraZeneca

Manufacturer Identification CodeRegistered

Authorized RepresentativeCorporate Representative

Compliance & StatusActive / Listed

Oncology Drugs & Clinical Formulations

Featured Drug Formulation

Enhertu

Generic: fam-trastuzumab deruxtecan-nxki

Class: Targeted Antibody-Drug Conjugate (ADC)

View Complete Drug Profile

Indications: Adult patients with unresectable or metastatic HER2-positive breast cancer, HER2-low breast cancer, HER2-mutant metastatic NSCLC, and locally advanced or metastatic HER2-positive gastric adenocarcinoma.

Direct Communication & Assistance

Send an Inquiry to Daiichi Sankyo & AstraZeneca

Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.